Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-039824

Director gave up 13,300 shares (to pay taxes)

  • Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WEISER MICHAEL Director 2017-06-12 Option exercise +15,000 $4.85 $72,750 218,670 D
WEISER MICHAEL Director 2017-06-12 Shares withheld for taxes −13,300 $5.47 $72,751 205,370 D
Derivatives
WEISER MICHAEL Director 2017-06-12 Option exercise · Stock Option (Right to Buy) −15,000 0 D
Loading xslF345X03/doc4.xml…